z-logo
open-access-imgOpen Access
Glomerular Hyperfiltration and β-2 Microglobulin As Biomarkers of Incipient Renal Dysfunction in Cancer Survivors
Author(s) -
Fernanda Rodrigues Tibúrcio,
Karla Emília de Sá Rodrigues,
André Rolim Belisário,
Ana Cristina Simões e Silva
Publication year - 2018
Publication title -
future science oa
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.825
H-Index - 23
ISSN - 2056-5623
DOI - 10.4155/fsoa-2018-0045
Subject(s) - renal function , medicine , creatinine , nephrotoxicity , urology , blood urea nitrogen , glomerular hyperfiltration , urinary system , cancer , endocrinology , gastroenterology , kidney , diabetic nephropathy
Herein, we aimed to evaluate the occurrence of impaired renal function after cancer treatment with potentially nephrotoxic chemotherapy in children. A cross-sectional study was performed in 41 cancer survivors after chemotherapy with potentially nephrotoxic drugs. 26 (63.4%) children were detected with glomerular hyperfiltration, and urinary levels of β-2 microglobulin (B2MG) were higher than reference range in all patients. Levels of B2MG were positively correlated with plasma creatinine and negatively correlated with glomerular filtration rate. Plasma creatinine, systolic blood pressure and cholesterol were independently associated with B2MG values. The final multivariate model for glomerular hyperfiltration risk included plasma levels of urea and of magnesium. Urinary levels of B2MG and glomerular hyperfiltration may emerge as potential biomarkers of early renal dysfunction in childhood cancer survivors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom